Latest News - Research and Publications

Wednesday, July 11, 2018

Fourth Generation Retinoid Shows Promise in Acne Trials

New research reveals that trifarotene, a fourth-generation retinoid with potent and selective activity against only one particular retinoic acid receptor, may have an improved efficacy and safety prof…

Read the full story

Wednesday, July 11, 2018

Dermtech’s Noninvasive Melanoma Screen Improves Care, Lowers Cost

New research shows that DermTech’s Pigmented Lesion Assay (PLA) reduces cost while improving the care of patients with primary pigmented skin lesions suggestive of melanoma. The research appears…

Read the full story

Wednesday, July 11, 2018

About 415 Million People May Have Rosacea Worldwide

As many as 415 million people worldwide may have rosacea, according to new research in the British Journal of Dermatology. Dr. Jacob Thyssen and colleagues at the University of Copenhagen, Denmark,…

Read the full story

Wednesday, July 11, 2018

Nanotechnology May Improve Onychomycosis, Cut Costs

Nanotechnology can improve efinaconazole treatment for onychomycosis and make it more cost effective, according to new research in the Journal of Drugs in Dermatology. Adam Friedman, MD, professor …

Read the full story

Wednesday, July 11, 2018

Life Sciences Industry Eyes $1.5 Trillion Milestone

The life sciences industry is nearing a $1.5 trillion milestone, according to an analysis from Frost & Sullivan. The firm’s Global Life Sciences Industry Outlook, 2018 report finds that…

Read the full story

Tuesday, July 10, 2018

Rare Pediatric Skin Conditions Often Get Expensive, Inconsistent Care

Children with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have high rates of complications -- resulting in long and costly hospital stays -- and that treatment strategies v…

Read the full story

Friday, July 06, 2018

Jury Still Out on Environmental Effects of Chemical Sunscreens

In the wake of Hawaiian legislation banning the sale and distribution of sunscreens containing oxybenzone and octinoxate because they may contribute to coral bleaching, new research reviews the availa…

Read the full story

Monday, July 02, 2018

PAH after Cryolipolysis May Not Be So 'Rare'

Paradoxical adipose hyperplasia (PAH) after cryolipolysis may be more common than previously thought according to a paper in the July issue of Plastic and Reconstructive Surgery®. While PA…

Read the full story

Tuesday, June 26, 2018

DermTech Initiating Study to Assess DNA Damage and Reversal

DermTech, Inc. has initiated enrollment in a clinical study to assess DNA damage induced by an excimer laser and evaluate the potential of T4 endonuclease topical DNA repair enzyme and photolyase…

Read the full story

Monday, June 25, 2018

First EB Patient Enrolled in PK Study of Diacerein 1% Ointment

The first patient has been enrolled in a new Phase 1 study evaluating the pharmacokinetics (PK) and safety of Castle Creek Pharmaceuticals’ diacerein 1% ointment (CCP-020) under maximum use cond…

Read the full story

Friday, June 15, 2018

New Data from DermTech Presented at International Investigational Dermatology Meeting

DermTech, Inc., has announced the publication of two clinical study abstracts at the 2018 International Investigational Dermatology meeting in Orlando, Fl. A real world clinical utility study, “…

Read the full story

Wednesday, June 13, 2018

Older Melanoma Patients May Have Better Response to Immune Checkpoint Blockade Therapy

Patient age correlates with response to immunotherapy in melanoma, and depleting regulatory T cells in young patients may have a therapeutic potential to enhance response in younger patients, accordin…

Read the full story

Monday, June 11, 2018

ThermiVa: First-ever Data Show Vaginal Regeneration

Thermi’s ThermiVa® device has been shown to deliver significant improvements in common vaginal disorders and improve sexual satisfaction, according to a study published in Dermatologic …

Read the full story

Friday, June 08, 2018

PellePharm Presents New Data in BCC

PellePharm, a late clinical-stage biopharmaceutical company committed to targeting rare dermatologic conditions at their source, presented new data from its clinical and scientific research programs a…

Read the full story

Friday, June 08, 2018

Galderma Global Survey Assesses Burden of Rosacea

    Recently released findings from Galderma’s global survey on the true burden of rosacea suggest a need for dermatologists and doctors to proactively open a dialogue with patie…

Read the full story
Load More